Bain and Cinven publish Stada offer document
Bain Capital and Cinven partners have published an offer document for the voluntary public takeover of Stada Arzneimittel through holding company Nidda Healthcare.
As previously reported, Nidda Healthcare is offering €66.00 per share comprising a cash consideration of €65.28 plus a €0.72 dividend. This offer values the company at €5.3bn, making it the largest private-equity-backed takeover bid ever launched in Germany.
The publication of the offer document marks the beginning of the acceptance period, which is expected to run from 27 April to 8 June 2017. The document has been approved by the German Federal Financial Supervisory Authority prior to publication, in accordance with German acquisition law.
More on Buyouts
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Main Capital’s Assessio to be sold to Pollen Street
Recruitment software company tripled in revenue under Main Capital’s ownership
Exponent divests ‘significant' stake in Meadow to Canadian investor
Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater